Finance

Lists
Why is SIBN down 2.28%?
Dive Deeper
SIBN:NASDAQ
SI-Bone Inc
$19.10
-2.28%
(-0.44) 1D
Oct 7, 11:31:47 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SIBN...
Open
$19.27
High
$19.69
Low
$19.04
Mkt. cap
856.26M
Avg. vol.
567.17K
Volume
73.80K
52-wk high
$21.89
52-wk low
$11.48
EPS
-$0.33
Beta
0.66
Shares outstanding
44.82M
No. of employees
376
Open
$19.27
High
$19.69
Low
$19.04
Mkt. cap
856.26M
Avg. vol.
567.17K
Volume
73.80K
52-wk high
$21.89
52-wk low
$11.48
EPS
-$0.33
Beta
0.66
Shares outstanding
44.82M
No. of employees
376
News stories
From web sources and news partners
About SI-Bone Inc
CEO-
Employees376
Founded2008
HeadquartersSanta Clara, California, United States
SectorMedical device
Websitesi-bone.com
Analyst ratings
Based on 7 analysts giving stock ratings to SIBN in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for SIBN in the last 3 months.
Highest
Current $19.10
$27.00 (+41.32%)
Average
$24.50 (+28.24%)
Lowest
$20.00 (+4.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
$27.00
+41.3%
09/29/2026
Travis Steed
Bank of America Securities
Buy
Maintained
-
-
08/04/2026
Richard Newitter
Truist Financial
Buy
Reiterated
$23.00
+20.4%
08/04/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$25.00
+30.9%
08/04/2026
David Saxon
Needham
Buy
Reiterated
$27.00
+41.3%
08/04/2026
Patrick Wood
UBS
Buy
Maintained
$25.00
+30.9%
08/04/2026
Mathew Blackman
TD Cowen
Buy
Reiterated
$20.00
+4.7%
08/04/2026
Unknown Analyst
UBS
Buy
Initiated
$24.00
+25.6%
07/28/2026
Andrew Ranieri
Morgan Stanley
Buy
Reiterated
$18.00
-5.8%
05/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
48.66M
56.35M
52.59M
56.01M
Cost of goods sold
9.81M
11.82M
10.64M
11.46M
Cost of revenue
9.81M
11.82M
10.64M
11.46M
Research and development expenses
4.24M
4.36M
4.19M
5.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.99M
42.63M
42.84M
44.13M
Operating expense
44.23M
46.99M
47.04M
49.35M
Total operating expenses
54.04M
58.81M
57.68M
60.82M
Operating income
-5.38M
-2.46M
-5.09M
-4.81M
Other non operating income
-
-
-
-
EBT including unusual items
-4.57M
-1.64M
-4.33M
-4.09M
EBT excluding unusual items
-4.57M
-1.64M
-4.33M
-4.09M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.57M
-1.64M
-4.33M
-4.09M
Net profit margin
-9.38%
-2.92%
-8.24%
-7.30%
Earnings per share
-0.11
-0.04
-0.10
-0.09
Interest and investment income
1.52M
1.45M
1.35M
1.33M
Interest expense
-670.00K
-630.00K
-592.00K
-598.00K
Net interest expenses
845.00K
817.00K
758.00K
734.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.90M
-825.00K
-3.48M
-3.13M
Gain or loss from assets sale
814.00K
185.00K
332.00K
254.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps